|
PCID2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.537600E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.080900E-03 |
| Normal-vs-Stage2 |
4.018000E-01 |
| Normal-vs-Stage3 |
2.286400E-01 |
| Normal-vs-Stage4 |
6.644000E-01 |
| Stage1-vs-Stage2 |
4.983000E-01 |
| Stage1-vs-Stage3 |
6.927000E-01 |
| Stage1-vs-Stage4 |
9.405700E-02 |
| Stage2-vs-Stage3 |
8.262800E-01 |
| Stage2-vs-Stage4 |
3.909200E-01 |
| Stage3-vs-Stage4 |
3.019600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.112200E-02 |
| Normal-vs-AfricanAmerican |
9.836000E-02 |
| Normal-vs-Asian |
7.670400E-02 |
| Caucasian-vs-AfricanAmerican |
9.297800E-01 |
| Caucasian-vs-Asian |
5.640800E-01 |
| AfricanAmerican-vs-Asian |
5.740000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.369800E-02 |
| Normal-vs-Female |
2.413000E-01 |
| Male-vs-Female |
4.849400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.128300E-02 |
| Normal-vs-Extreme_Weight |
2.556300E-02 |
| Normal-vs-Obese |
2.227400E-01 |
| Normal-vs-Extreme_Obese |
1.108320E-02 |
| Normal_Weight-vs-Extreme_Weight |
8.832200E-01 |
| Normal_Weight-vs-Obese |
4.965600E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.927600E-01 |
| Extreme_Weight-vs-Obese |
3.624200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
3.780400E-01 |
| Obese-vs-Extreme_Obese |
1.829160E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.890350E-02 |
| Normal-vs-Age(41-60Yrs) |
6.275600E-01 |
| Normal-vs-Age(61-80Yrs) |
8.442700E-03 |
| Normal-vs-Age(81-100Yrs) |
1.027780E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.360290E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.426200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.469600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.063540E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.944400E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.621800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.966600E-01 |
| Normal-VS-Type2 PRCC |
1.484540E-03 |
| Normal-VS-KIRP CIMP |
4.061700E-03 |
| Normal-VS-Unclassified PRCC |
2.936400E-01 |
| Type1 PRCC-VS-Type2 PRCC |
3.143700E-03 |
| Type1 PRCC-VS-KIRP CIMP |
6.114000E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
6.118600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
6.553000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.514780E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.107000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.197100E-03 |
| Normal-vs-N1 |
8.117600E-01 |
| Normal-vs-N2 |
7.178100E-03 |
| N0-vs-N1 |
1.338360E-01 |
| N0-vs-N2 |
1.885980E-01 |
| N1-vs-N2 |
1.576760E-01 |
|
|
